Clinical Trials Browser

Carcinoma, Hepatocellular

NCT04234113 2026-03-27

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02439008 2026-03-13

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Phase NA Terminated

28 enrolled

DermatologicGastrointestinalGenitourinary

Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Colorectal Neoplasms

Clinical Trials

LIDA-BII

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

REPLACE

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of Recurrence

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Liver and Biliary Tumor Tissue Registry

Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer

IMMUNOCELL

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

A Study of HFB301001 in Adult Patients With Advanced Solid Tumors

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Nivolumab Combined With BMS-986253 in HCC Patients

A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

LOST-B

RHEPaiR

PANORAMA

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

Study of INCA 0186 in Subjects With Advanced Solid Tumors

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

HOMIE-166

Study of Pembrolizumab and Radiotherapy in Liver Cancer

AM-003

STARBURST

To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer

STOP-HCC

MHALT

A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

ABE-LIVER

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

Study of INCB086550 in Select Solid Tumors

ADVANCE HCC

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

ABT-888 and Temozolomide for Liver Cancer

MYCHELANGELO I

Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma